financetom
Market
financetom
/
Market
/
Commerzbank on Overnight News
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Commerzbank on Overnight News
Apr 10, 2025 3:36 AM

06:13 AM EDT, 04/10/2025 (MT Newswires) -- Commerzbank in its "European Sunrise" note of Thursday highlighted:

Markets: Risk-on with Nasdaq rallying 12%, S&P up 9.5% in record volume after United States tariff pause announcement, e-minis remain close to the highs in Asia and Nikkei is up 8%. Bund future drops sharply on tariff pause, opens higher in Asia. Two-year US Treasuries rise some 30bps above 4% before consolidating, longer-tenors are better supported. Solid 10-year UST auction. EUR drops back below $1.10. Brent is up at $64.6/barrel.

Fed: Minutes for the March meeting state that inflation could be more persistent, stagflation risks are looming and tariffs are likely to increase inflation this year. Minneapolis Federal Reserve President Neel Kashkari says that "hurdle to cut rates remains high" and uncertainty about tariffs may lead to economic downturn. Federal Reserve Bank of Cleveland President Beth Hammack calls current monetary policy "modestly restrictive." Michelle Bowman says at the nomination hearing she will prioritize reforming supervision.

US: Atlanta Fed GDPNow rises to -2.42% from -2.85% for Q1. House delays vote on tax cuts and debt limit.

==EUROPE:

ECB: European Central Bank Governing Council member Francois Villeroy de Galhau calls U.S. President Donald Trump's decision on tariffs "a return to economic reason," he doesn't expect an increase in inflation in Europe.

France: Finance Minister Eric Lombard confirms plans for 5.4% budget deficit.

Germany: SPD members to vote on coalition treaty by April 30. Incoming Prime Minister Friedrich Merz promises that the corporate tax cuts are independent of financing questions.

Spain: PM Pedro Sanchez calls U.S. tariffs unjust and harmful, while a pause can lead to negotiations.

==ASIA:

China: CPI falls to -0.1% year over year in March, while the consensus was 0% and the producer price index drops to -2.5%, while the consensus was -2.3%.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Stantec Up in U.S. Pre-market on Higher Dividend, Q4 Adjusted Earnings Beat
Stantec Up in U.S. Pre-market on Higher Dividend, Q4 Adjusted Earnings Beat
Feb 25, 2025
08:06 AM EST, 02/25/2025 (MT Newswires) -- Stantec ( STN ) traded 1.3% higher at last look Tuesday in NYSE pre-market trading as the company increased its dividend following a fourth-quarter adjusted earnings beat. The company will pay a dividend of $0.225 per share, a 7.1% increase, on April 15 to shareholders of record on March 28. The sustainable design...
Traders Eye Nvidia Earnings, Driving Muted Pre-Bell Action for US Equity Futures
Traders Eye Nvidia Earnings, Driving Muted Pre-Bell Action for US Equity Futures
Feb 25, 2025
08:18 AM EST, 02/25/2025 (MT Newswires) -- US equity futures were little changed pre-bell Tuesday, with investor sentiment largely muted ahead of crucial earnings results from chipmaker Nvidia ( NVDA ) later in the week. Nvidia ( NVDA ) is scheduled to release its quarterly earnings after the closing bell on Wednesday. Oil prices were lower, with front-month global benchmark...
US STOCKS-Futures slip after US plans tighter trade curbs; Nvidia falls
US STOCKS-Futures slip after US plans tighter trade curbs; Nvidia falls
Feb 25, 2025
(For a Reuters live blog on U.S., UK and European stock markets, click/ or type LIVE/ in a news window.) * Home Depot ( HD ) falls on downbeat annual same-store sales growth forecast * Zoom Communications ( ZM ) slips on bleak revenue outlook * Conference Board's gauge of consumer confidence due at 10 a.m. ET * Futures: Dow...
Eupraxia Surges 15% in U.S. Pre-market Trading After Reporting Positive Data From Resolve Phase 1b/2a Trial
Eupraxia Surges 15% in U.S. Pre-market Trading After Reporting Positive Data From Resolve Phase 1b/2a Trial
Feb 25, 2025
08:03 AM EST, 02/25/2025 (MT Newswires) -- Eupraxia Pharmaceuticals ( EPRX ) rose 15% in U.S. pre-market trading on Tuesday after announcing additional positive clinical data from its Resolve Phase 1b/2a trial. The ongoing trial, which is evaluating EP-104GI for the treatment of eosinophilic esophagitis, an inflammatory disease of the esophagus, showed that histological scores and symptom scores continue to...
Copyright 2023-2025 - www.financetom.com All Rights Reserved